obviously allows other partners to be more actively involved, maybe the ceo has that up his sleeve after all; again I seriously doubted that 6 months ago with the free renewal, but possibly things have moved along since then.
Maybe? Possibly? Seriously doubted? You slammed anyone with a different view, and set yourself up as resident expert. So.
Is this the closest you ever get to admitting "I was wrong"?
Things have indeed moved on from the option extension, which was only ever a positive event because the request for the extension came along with a request from Celgene to extend the scope of the applications under the option. How did you manage to miss that key point? Celgene wanted the security of the option, MSB didn't mind giving them some because of the extension of the applications. Why did you refuse point blank to concede this, and now acting as if it's all new?
Why would Celgene move on after the FDA listing when they clearly asked for the scope of applications to be extended. What you write is not just creative, it defies logic.
What has indeed moved on is that while positive events that were then understood and interpreted correctly by some, other people like your good self have finally digested those as realities. Fast tracking by the FDA is one development which was loudly pooh poohed by posters of that ilk, but it's a reality. (Clinical results? Don't bore you?)
MSB is hardly in a desperate situation and never has been, because anyone who reads and understands the results knows they have solid proven science behind them, enough for the FDA to set out a pathway for fast tracking. MSB are trail blazing, it's a first and the risks which apply to pharmaceutical drugs don't apply to stem cells. This is blinding clear, but it was foreshadowed by me a long time ago, and loudly denigrated by posters whose credibility should be in shreds. Don't bore you with that either?
Indeed, the risks have been persistently overblown by some posters who for some reason, if they can't find any real ones will extrapolate to find some imaginary ones. The persistent ability to ignore plain logic, or obvious facts when applying plain logic and then concede in the most minimal way, if at all, is a bizarre talent I can only admire.
Both parties are working to an optimal outcome and quantifying the amounts involved and negotiating across a wide range of applications is always going to be protracted.
At least you have in a very mealy mouthed way, conceded that indeed MSB is in effect, in a much stronger position than you had claimed. Mainly because it's an unavoidable fact.
(20min delay)